Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer

Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer

Item
http://www.wikidata.org/entity/Q36834005
Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan.Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management.Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers.Expression of PACAP and PAC1 Receptor in Normal Human Thyroid Gland and in Thyroid Papillary Carcinoma.Development by Genetic Immunization of Monovalent Antibodies Against Human Vasoactive Intestinal Peptide Receptor 1 (VPAC1), New Innovative, and Versatile Tools to Study VPAC1 Receptor Function.Review on PACAP-Induced Transcriptomic and Proteomic Changes in Neuronal Development and Repair.Presence and Effects of Pituitary Adenylate Cyclase Activating Polypeptide Under Physiological and Pathological Conditions in the Stomach.Neuropeptide G Protein-Coupled Receptors as Oncotargets.Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity
P2860

Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer

Item
http://www.wikidata.org/entity/Q36834005
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Vasoactive intestinal peptide/ ...... and their receptors and cancer
@en
type
label
Vasoactive intestinal peptide/ ...... and their receptors and cancer
@en
prefLabel
Vasoactive intestinal peptide/ ...... and their receptors and cancer
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Vasoactive intestinal peptide/ ...... and their receptors and cancer
@en
P2093
P2860
P304
P31
P356
10.1097/MED.0000000000000218
P433
P478
P577
P698
P932